• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[钠钾ATP酶内源性抑制剂的细胞化学证明及其与家族性动脉高血压的关系]

[Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].

作者信息

de Wardener H

出版信息

Nephrologie. 1987;8(1):3-6.

PMID:3035398
Abstract

Acute volume expansion, an increase in sodium intake and a restraint on sodium excretion endow the plasma with the capacity to cause a natriuresis, to inhibit sodium transport and to stimulate vascular reactivity. One natriuretic substance, the atrial natriuretic peptide, has been identified. Cytochemical techniques can detect the presence of a Na-K ATPase inhibitor in the plasma of normal man and the rat, the concentration of which is controlled by salt intake. The substance responsible appears to originate in the hypothalamus. The plasma concentration of the cytochemically detectable Na-K ATPase inhibitor is substantially raised in the plasma of patients with essential hypertension, of the spontaneously hypertensive rat and of the Milan hypertensive rat. An hypothesis is put forward that links salt intake, a genetic renal lesion, the endogenous Na-K ATPase inhibitor, the atrial natriuretic peptide, and the substance responsible for vascular reactivity, with the rise in arterial pressure in hereditary forms of hypertension.

摘要

急性血容量扩张、钠摄入增加以及钠排泄受限使血浆具有引起利钠作用、抑制钠转运和刺激血管反应性的能力。一种利钠物质,即心钠素,已被识别。细胞化学技术可检测到正常人和大鼠血浆中存在钠钾ATP酶抑制剂,其浓度受盐摄入量控制。相关物质似乎起源于下丘脑。在原发性高血压患者、自发性高血压大鼠和米兰高血压大鼠的血浆中,细胞化学可检测到的钠钾ATP酶抑制剂的血浆浓度显著升高。有人提出一种假说,将盐摄入、遗传性肾损害、内源性钠钾ATP酶抑制剂、心钠素以及负责血管反应性的物质与遗传性高血压形式的动脉压升高联系起来。

相似文献

1
[Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].[钠钾ATP酶内源性抑制剂的细胞化学证明及其与家族性动脉高血压的关系]
Nephrologie. 1987;8(1):3-6.
2
The endogenous cytochemically assayable Na-K-ATPase inhibitor and its relation to hypertension.
Klin Wochenschr. 1987;65 Suppl 8:4-7.
3
Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.
Hypertension. 1987 Nov;10(5 Pt 2):I52-6. doi: 10.1161/01.hyp.10.5_pt_2.i52.
4
Cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating/Na-K-ATPase-inhibiting activity of plasma and hypothalamus in reduced renal mass hypertension.
Am J Hypertens. 1991 Apr;4(4 Pt 1):315-20. doi: 10.1093/ajh/4.4.315.
5
The relation of the natriuretic hormone to essential hypertension.利钠激素与原发性高血压的关系。
Postgrad Med J. 1983;59 Suppl 2:74-7.
6
Na-K-ATPase-inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat.
J Endocrinol. 1986 Jan;108(1):69-73. doi: 10.1677/joe.0.1080069.
7
[The role of the Na, K-ATPase inhibitor in renal sodium handling in patients with essential hypertension].[钠钾-ATP酶抑制剂在原发性高血压患者肾脏钠处理中的作用]
Nihon Jinzo Gakkai Shi. 1989 Jul;31(7):775-81.
8
PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.PST 2238:一种在遗传性高血压中调节钠钾ATP酶的新型抗高血压化合物。
J Pharmacol Exp Ther. 1999 Mar;288(3):1074-83.
9
Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma.
Hypertension. 1987 May;9(5):498-503. doi: 10.1161/01.hyp.9.5.498.
10
[Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].[正常血压受试者中具有利钠和钠钾ATP酶抑制特性的血浆的存在及调节]
Arch Mal Coeur Vaiss. 1987 Jun;80(6):960-5.

引用本文的文献

1
Effect of tissue specificity of brain soluble fractions on Na+, K(+)-ATPase activity.脑可溶性组分的组织特异性对钠钾ATP酶活性的影响。
Neurochem Res. 1990 Mar;15(3):289-94. doi: 10.1007/BF00968674.